BioCentury
ARTICLE | Company News

Management tracks: eGenesis names Sekhri CEO

January 17, 2019 11:17 PM UTC

Xenotransplantation company eGenesis Inc. (Cambridge, Mass.) hired Paul Sekhri as president and CEO. He succeeds interim CEO Julie Sunderland, who will become a director. Sekhri was president and CEO of Lycera Corp. (Ann Arbor, Mich.) and, before that, group EVP, global business development and chief strategy officer at Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA).

Renal disease company Tricida Inc. (NASDAQ:TCDA) hired Susannah Cantrell as chief commercial officer and SVP. She was VP and head, global commercial strategy and marketing oncology at Gilead Sciences Inc. (NASDAQ:GILD)...